1.81
전일 마감가:
$1.89
열려 있는:
$1.87
하루 거래량:
358.06K
Relative Volume:
1.19
시가총액:
$119.24M
수익:
-
순이익/손실:
$-86.08M
주가수익비율:
-0.839
EPS:
-2.1574
순현금흐름:
$-72.06M
1주 성능:
-18.47%
1개월 성능:
+24.83%
6개월 성능:
+89.33%
1년 성능:
+25.69%
Io Biotech Inc Stock (IOBT) Company Profile
명칭
Io Biotech Inc
전화
(457) 070-2980
주소
OLE MAALOES VEH 3, COPENHAGEN
IOBT을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
IOBT
Io Biotech Inc
|
1.81 | 129.13M | 0 | -86.08M | -72.06M | -2.1574 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
![]()
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Io Biotech Inc 주식(IOBT)의 최신 뉴스
Major Phase 3 Results Coming: IO Biotech's Novel Melanoma Treatment Could Challenge Standard of Care - Stock Titan
IO Biotech Stock (IOBT) Opinions on Phase 3 Clinical Trial Risks - Quiver Quantitative
Forecasting IO Biotech Inc. price range with options dataFree Step-by-Step Stock Investment Guide - Newser
IO Biotech to announce Phase 3 melanoma treatment results By Investing.com - Investing.com Canada
IO Biotech to announce Phase 3 melanoma treatment results - Investing.com
IO Biotech to Announce Pivotal Phase 3 Trial Results on August 11, 2025. - AInvest
IO Biotech to Announce Topline Results of Pivotal Phase 3 Trial of Cylembio® in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma - The Manila Times
Identifying reversal signals in IO Biotech Inc.Free Long Hold Safe Return Strategy - Newser
IO Biotech (IOBT) Projected to Post Earnings on Tuesday - Defense World
Why IO Biotech Inc. is moving todayEntry Zone Forecast for Momentum Trading - Newser
IO Biotech IOBT 2025Q2 Earnings Preview Downside Ahead on Revenue Challenges - AInvest
T Inc. this weekYield Curve Outlook and Long-Term Implication Summary - Newser
Professional Diversity Network Inc. stock momentum explainedReversal Pattern Insights with Entry Tips - Newser
Live market analysis of IO Biotech Inc.Free Wealth Building Stock Market Ideas - Newser
What high frequency data says about IO Biotech Inc.Market Sentiment Tracker with Smart Alerts - Newser
Volatility clustering patterns for IO Biotech Inc.Free Trade Ready Stock Watch for Short Term - Newser
Using fundamentals and technicals on IO Biotech Inc.Free Low Risk Picks for Daily Trading - Newser
Is IO Biotech Inc. a candidate for recovery playSmart Trade Forecast Based on Neural Logic - Newser
Custom watchlist performance reports with IO Biotech Inc.Early Entry Ideas with Momentum Potential - Newser
Real time pattern detection on IO Biotech Inc. stockFree Risk Adjusted Technical Entry Plan - Newser
Published on: 2025-08-08 18:40:49 - Newser
Published on: 2025-08-09 03:08:59 - Newser
Will IO Biotech Inc. benefit from macro trendsInvestment Timing Strategy with Market Filters - Newser
Developing predictive dashboards with IO Biotech Inc. dataAI Short-Term Gain Forecast with Data - Newser
Why IO Biotech Inc. stock attracts strong analyst attentionFree Alpha Driven Watchlist With Alerts - Newser
Option-related insider selling at Toromont Industries (TIH) - The Globe and Mail
What makes IO Biotech Inc. stock price move sharplyGrowth Watchlist for Long Term Positioning - Newser
Exit strategy if you’re trapped in IO Biotech Inc.Free Intraday Trend Analysis for Fast Gains - Newser
Is IO Biotech Inc. stock overhyped or has real potentialWeekly Signal Report with Trend Summary - Newser
Regression analysis insights on IO Biotech Inc. performanceFree Growth Based Stock Signal Screener - Newser
How IO Biotech Inc. stock performs during market volatilityStock Entry Point Planner with Volume Spike - Newser
Is IO Biotech Inc. stock a good hedge against inflationReal-Time Setup Summary with ROI Focus - Newser
MDA SPACE AWARDED CONTRACTS FOR ROYAL CANADIAN NAVY UNCREWED AIRCRAFT SYSTEMS TO ENHANCE MARITIME OPERATIONS - The Globe and Mail
Is IO Biotech Inc. stock ready for a breakoutSmart Trade Mapping with Entry Details - Newser
Bull of the Day: Meta Platforms (META) - The Globe and Mail
Order Book Volume Tilts Bullish on IO Biotech Inc.Market Entry and Exit Point Tips From Traders - metal.it
Published on: 2025-08-04 00:17:08 - Newser
Smart tools for monitoring IO Biotech Inc.’s price actionPredictive Model for Intraday Swing Forecast - Newser
Should I hold or sell IO Biotech Inc. stock in 2025Explosive earning power - Jammu Links News
What analysts say about IO Biotech Inc. stockFree Stock Market Trend Analysis - Jammu Links News
Is it the right time to buy IO Biotech Inc. stockTriple returns potential - Jammu Links News
What is the risk reward ratio of investing in IO Biotech Inc. stockTriple-digit wealth increases - Jammu Links News
Is IO Biotech Inc. a good long term investmentBuild capital through low-risk investments - Jammu Links News
Is CIM.PRD a good long term investmentMassive stock growth - Jammu Links News
What catalysts could drive IO Biotech Inc. stock higher in 2025Achieve rapid capital gains with smart investing - Jammu Links News
How many analysts rate IO Biotech Inc. as a “Buy”Get daily updates on promising stocks - Jammu Links News
How volatile is IO Biotech Inc. stock compared to the marketGet daily expert analysis for smarter investing - Jammu Links News
How strong is IO Biotech Inc. company’s balance sheetIdentify undervalued stocks ready to soar - Jammu Links News
Io Biotech Inc (IOBT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):